S&P 500
(-0.41%) 5 460.48 points
Dow Jones
(-0.12%) 39 119 points
Nasdaq
(-0.71%) 17 733 points
Oil
(-0.34%) $81.46
Gas
(-3.13%) $2.60
Gold
(0.01%) $2 336.90
Silver
(0.61%) $29.44
Platinum
(0.28%) $1 009.00
USD/EUR
(-0.06%) $0.933
USD/NOK
(0.45%) $10.68
USD/GBP
(-0.04%) $0.791
USD/RUB
(0.86%) $85.73

Realaus laiko atnaujinimai Charmacy Pharmaceutical [2289.HK]

Birža: HKSE Sektorius: Healthcare Pramonė: Medical Distribution
Atnaujinta25 birž. 2024 @ 09:25

0.00% HKD 8.60

Live Chart Being Loaded With Signals

Commentary (25 birž. 2024 @ 09:25):
No signals from the correlation tool

Charmacy Pharmaceutical Co., Ltd. engages in the trading of pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and terminal chemists...

Stats
Šios dienos apimtis 3 000
Vidutinė apimtis 71 966
Rinkos kapitalizacija 928.80M
EPS HKD0.230 ( Q4 | 2023-12-31 )
Last Dividend HKD0.499 ( 2023-06-29 )
Next Dividend HKD0 ( N/A )
P/E 16.86
(Sector) 14.27
(Industry) 0
ATR14 HKD0 (0.00%)
0673.HK -3.06%
0718.HK 15.15%
1099.HK 0.97%
1931.HK 0.00%
2192.HK 0.00%
2289.HK 0.00%
2607.HK 0.86%
Koreliacija (AI algo v.1.1b): Paired value (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Charmacy Pharmaceutical Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Charmacy Pharmaceutical Finansinės ataskaitos

Annual 2023
Pajamos: HKD4.40B
Bruto pelnas: HKD292.74M (6.65 %)
EPS: HKD0.480
FY 2023
Pajamos: HKD4.40B
Bruto pelnas: HKD292.74M (6.65 %)
EPS: HKD0.480
FY 2022
Pajamos: HKD4.18B
Bruto pelnas: HKD268.61M (6.43 %)
EPS: HKD0.840
FY 2021
Pajamos: HKD3.79B
Bruto pelnas: HKD237.22M (6.25 %)
EPS: HKD0.221

Financial Reports:

No articles found.

Charmacy Pharmaceutical Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.949
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

Charmacy Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 5.24 - average (41.79%) | Divividend Growth Potential Score: 3.37 - Decrease likely (32.62%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.229 2016-11-14
Last Dividend HKD0.499 2023-06-29
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 9 --
Total Paid Out HKD2.57 --
Avg. Dividend % Per Year 0.00% --
Score 1.88 --
Div. Sustainability Score 5.24
Div.Growth Potential Score 3.37
Div. Directional Score 4.30 --
Next Divdend (Est)
(2024-10-07)
HKD0 Estimate 0.00 %
Dividend Stability
0.05 Very Bad
Dividend Score
1.88
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date Amount Declaration Date Record Date Payment Date
29 Jun 2023 HKD0.499 30 Nov -0001 30 Nov -0001 30 Nov -0001
02 Jun 2023 HKD0.450 30 Nov -0001 30 Nov -0001 30 Nov -0001
02 Jun 2021 HKD0.242 30 Nov -0001 30 Nov -0001 30 Nov -0001
27 May 2020 HKD0.219 31 Mar 2020 28 May 2020 10 Jul 2020
05 Jun 2019 HKD0.341 26 Mar 2019 06 Jun 2019 08 Jul 2019
30 May 2018 HKD0.246 22 Mar 2018 31 May 2018 03 Jul 2018
15 Nov 2017 HKD0.118 24 Aug 2017 16 Nov 2017 15 Dec 2017
13 Jun 2017 HKD0.229 22 Mar 2017 14 Jun 2017 17 Jul 2017
14 Nov 2016 HKD0.229 22 Aug 2016 15 Nov 2016 15 Dec 2016

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
1857.HK Ex Dividend Junior 2023-08-23 Semi-Annually 0 0.00%
0217.HK Ex Dividend Junior 2023-07-05 Sporadic 0 0.00%
1286.HK Ex Dividend Knight 2023-08-21 Semi-Annually 0 0.00%
3718.HK Ex Dividend Knight 2023-09-11 Semi-Annually 0 0.00%
0857.HK Ex Dividend Knight 2023-09-12 Semi-Annually 0 0.00%
2111.HK Ex Dividend Knight 2023-09-13 Annually 0 0.00%
0393.HK Ex Dividend Knight 2023-09-14 Semi-Annually 0 0.00%
1598.HK Ex Dividend Junior 2023-07-13 Annually 0 0.00%
0057.HK Ex Dividend Knight 2023-09-01 Semi-Annually 0 0.00%
6826.HK Ex Dividend Knight 2023-07-04 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.01171.5009.7710.00[0 - 0.5]
returnOnAssetsTTM0.01581.2009.4710.00[0 - 0.3]
returnOnEquityTTM0.08771.500-0.136-0.205[0.1 - 1]
payoutRatioTTM1.470-1.00010.00-10.00[0 - 1]
currentRatioTTM1.0740.8009.637.71[1 - 3]
quickRatioTTM0.6150.800-1.089-0.871[0.8 - 2.5]
cashRatioTTM0.2421.5009.7710.00[0.2 - 2]
debtRatioTTM0.481-1.5001.987-2.98[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM-0.8942.00-0.298-0.596[0 - 30]
freeCashFlowPerShareTTM-1.2722.00-0.636-1.272[0 - 20]
debtEquityRatioTTM2.61-1.50010.00-10.00[0 - 2.5]
grossProfitMarginTTM0.06551.000-2.24-2.24[0.2 - 0.8]
operatingProfitMarginTTM0.02461.000-1.508-1.508[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.06181.000-1.455-1.455[0.2 - 2]
assetTurnoverTTM1.3560.8004.293.43[0.5 - 2]
Total Score5.24

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM16.831.0008.400[1 - 100]
returnOnEquityTTM0.08772.50-0.0877-0.205[0.1 - 1.5]
freeCashFlowPerShareTTM-1.2722.00-0.424-1.272[0 - 30]
dividendYielPercentageTTM4.121.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM-0.8942.00-0.298-0.596[0 - 30]
payoutRatioTTM1.4701.50010.00-10.00[0 - 1]
pegRatioTTM2.951.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.02191.000-3.050[0.1 - 0.5]
Total Score3.37

Charmacy Pharmaceutical Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Charmacy Pharmaceutical

Charmacy Pharmaceutical Co., Ltd. engages in the trading of pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and terminal chemists. It also operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online and make inquiries and payments. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was incorporated in 1984 and is headquartered in Shantou, the People's Republic of China.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.

Total Execution Time: 1.7388589382172 seconds
Number of API calls: 3
Number of DB calls: 9